741721-49-3

Usage

Uses

Used in Pharmaceutical Industry:
2,5-difluoro-3-nitrobenzoic acid is used as a building block for the synthesis of various pharmaceuticals. Its unique chemical properties and reactive functional groups make it a valuable compound in the development of new drugs.
Used in Agrochemical Industry:
2,5-difluoro-3-nitrobenzoic acid is also used as a building block in the synthesis of agrochemicals. Its versatile nature allows it to be incorporated into various agrochemical products.
Used in Organic Materials:
2,5-difluoro-3-nitrobenzoic acid is used in the development of organic materials. Its unique chemical properties and reactive functional groups contribute to the creation of new materials with specific properties.
Used in Materials Science:
2,5-difluoro-3-nitrobenzoic acid has been studied for its potential applications in materials science. Its unique chemical properties and reactive functional groups make it a promising candidate for research in this field.
Used as a Precursor in Organic Synthesis:
2,5-difluoro-3-nitrobenzoic acid is used as a precursor in organic synthesis. Its versatile nature and reactive functional groups make it a valuable starting material for the synthesis of various organic compounds.

Upstream product

• 2991-28-8 2,5-difluorobenzoic acid 

Downstream Products

• 741721-51-7 1-bromo-2,5-difluoro-3-nitrobenzene 
• 1154278-08-6 methyl 2,5-difluoro-3-nitrobenzoate 

Relevant academic research and scientific papers

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I) and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment

IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS

Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS

Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents

We describe a novel class of benzocycloheptanone derived oxazolidinone antibacterial agents. The synthesis and antibacterial activities with structure variation is discussed.

ANTIBACTERIAL AGENTS

Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications including use as antibacterial agents.